肾移植后早期检测尿转化生长因子β的临床意义
肾移植,,肾移植;肾病;转移生长因子β,0引言,1对象和方法,2结果,3讨论,【参考文献】
Clinical significance of urine TGFβ1 in predicting longterm renal allograft functionWANG PingXian, FAN MingQi, JIA WeiSheng,FENG JiaYu, XIAO Ya, FANG ZhenQiang, HUANG ChiBing, ZHANG YinPu
Department of Urinary Surgery, Second Hospital, Third Military Medical University, Chongqing 400037, China
【Abstract】 AIM: To determine the association between urine transforming growth factor β1(TGFβ1)concentration in early posttransplant time and longterm renal allograft function. METHODS: Blood and urine TGFβ1 concentrations were tested in renal recipients who had had kidney transplantation for one year and whose renal functions were normal from August 1, 1999 to April 30, 2001. One hundred and twentysix cases completed the 3year followup. Correlation between their renal functions (creatinine clearance rates, Ccr) and their urine TGFβ1 relative concentrations after 1 year of renal transplantation were determined. Losses of Ccr and numbers of renal dysfunction in groups with different urine TGFβ1 concentrations were compared. Of the 126 cases, 15 renal recipients were diagnosed as chronic allograft nephropathy (CAN). Their blood and urine TGFβ1 concentrations and other factors after 1 year of renal transplantation were compared with those of the normal renal recipients who had no CAN. RESULTS: Urine TGFβ1 relative concentrations after 1 year of renal transplantation in the 126 patients mentioned above were 138.1-437.5 ng/g. There was a positive correlation between the longterm renal functions (Ccr) and the urine TGFβ1 relative concentrations after 1 year of renal transplantation. The patients with higher urine TGFβ1 concentration 1 year after renal transplantation had more loss of Ccr in the next 3 years than those with lower urine TGFβ1 concentration. One year after renal transplantation, the urine TGFβ1 concentrations of CAN and noCAN recipients were (184.4±38.7) and (399.0±37.5) ng/g respectively, with significant difference. The blood TGFβ1 concentrations of CAN and no CAN recipients were (33.3±5.4) and (32.7±5.1) μg/L respectively, with no significant difference. CONCLUSION: TGFβ1 may play an important role in CAN. Urine TGFβ1 is significantly higher before renal dysfunction in patients with CAN. The level of urine TGFβ1 in early stage after renal transplantation can be used to predict the longterm renal function. ......
您现在查看是摘要页,全文长 10734 字符。